Back
BioXcel Therapeutics Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
41
BTAI
BioXcel Therapeutics
Last Price:
0.64
Seasonality Move:
71.25%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- The current trend is relatively stagnant and BTAI is experiencing selling pressure, which indicates risk of future bearish movement.
BioXcel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.65 | Sell |
| 20-day SMA: | 0.59 | Buy |
| 50-day SMA: | 0.6 | Buy |
| 200-day SMA: | 1.75 | Sell |
| 8-day EMA: | 0.65 | Sell |
| 20-day EMA: | 0.62 | Buy |
| 50-day EMA: | 0.67 | Sell |
| 200-day EMA: | 2.2 | Sell |
BioXcel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 54.58 | Buy |
| Chaikin Money Flow: | -241473 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.54 - 0.64) | Buy |
| Bollinger Bands (100): | (0.55 - 1.13) | Sell |
BioXcel Therapeutics Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioXcel Therapeutics Stock
Is BioXcel Therapeutics Stock a Buy?
- BioXcel Therapeutics share price is 0.64 while BTAI 8-day simple moving average is 0.65, which is a Sell signal.
- The stock price of BTAI is 0.64 while BioXcel Therapeutics 20-day SMA is 0.59, which makes it a Buy.
- BioXcel Therapeutics 50-day simple moving average is 0.60 while BTAI share price is 0.64, making it a Buy technically.
- BTAI stock price is 0.64 and BioXcel Therapeutics 200-day simple moving average is 1.75, creating a Sell signal.
BTAI Technical Analysis vs Fundamental Analysis
Sell
41
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy or a Sell?
-
BioXcel Therapeutics stock is rated a Sell
The current BioXcel Therapeutics [BTAI] share price is $0.64. The Score for BTAI is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
BioXcel Therapeutics Stock Info
Market Cap:
26.2M
Price in USD:
0.64
Share Volume:
276.62K
BioXcel Therapeutics 52-Week Range
52-Week High:
5.62
52-Week Low:
0.51
Sell
41
BioXcel Therapeutics (BTAI)
is a Sell
BioXcel Therapeutics Share Price Forecast
-
What is the BioXcel Therapeutics stock price today?
The BioXcel Therapeutics stock price is 0.64 USD today. -
Will BTAI stock go up or go down?
BioXcel Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is BioXcel Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioXcel Therapeutics is overvalued.
Is BioXcel Therapeutics Stock a Buy?
- BioXcel Therapeutics share price is 0.64 while BTAI 8-day exponential moving average is 0.65, which is a Sell signal.
- The stock price of BTAI is 0.64 while BioXcel Therapeutics 20-day EMA is 0.62, which makes it a Buy.
- BioXcel Therapeutics 50-day exponential moving average is 0.67 while BTAI share price is 0.64, making it a Sell technically.
- BTAI stock price is 0.64 and BioXcel Therapeutics 200-day simple moving average is 2.20, creating a Sell signal.
Fundamental Analysis of BioXcel Therapeutics
Is BioXcel Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.99 per share, and an increase next year of $0.47 per share.
Technical Analysis of BioXcel Therapeutics
Should I short BioXcel Therapeutics stock?
- BTAI Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting BioXcel Therapeutics is a Buy
- BioXcel Therapeutics Relative Strength Index (RSI) is 54.58, which suggest BioXcel Therapeutics is overbought
- The Bollinger Bands (25) for BioXcel Therapeutics is (0.54 - 0.64), which suggest BioXcel Therapeutics is a Sell
- The Bollinger Bands (100) for BioXcel Therapeutics is (0.55 - 1.13), which suggest BioXcel Therapeutics is a Sell
* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.